APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pediatric Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Research

Pediatric Vaccines Industry Research Report 2026

27 December 2025143 pages

Choose your research edition.

Industry ResearchPediatric Vaccines Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pediatric Vaccines Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Pediatric Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pediatric Vaccines Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Pediatric Vaccines Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Pediatric Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Pediatric Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Pediatric Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Pediatric Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Pediatric Vaccines include Bavarian Nordic, Bharat Biotech, Crucell, Dynavax, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, S K Chemicals and Serum Institute of India, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Pediatric Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Pediatric Vaccines Market by Company

Bavarian Nordic

Bharat Biotech

Crucell

Dynavax

LG Life Sciences

Lupin

Mitsubishi Tanabe Pharma

S K Chemicals

Serum Institute of India

Sinovac Biotech

AstraZeneca

Baxter

GlaxoSmithKline

Pfizer

Merck

Novartis

Sanofi

Shenzhen Kangtai Biological Products

Takeda Pharmaceutical

Janssen

Pediatric Vaccines Segment by Type

Meningococcal Diseases

Influenza

Hepatitis

Pneumococcal Diseases

Diphtheria

Others

Pediatric Vaccines Segment by Application

Infant

Newborn

Dolescent

Child

Pediatric Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pediatric Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Pediatric Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Pediatric Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Pediatric Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Pediatric Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Pediatric Vaccines Sales (W Units) of Manufacturers (2021-2026) Table 7. Global Pediatric Vaccines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Pediatric Vaccines Revenue of Manufacturers (2021-2026) Table 9. Global Pediatric Vaccines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Pediatric Vaccines Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Pediatric Vaccines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Pediatric Vaccines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Pediatric Vaccines, Product Type & Application Table 14. Global Pediatric Vaccines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Pediatric Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Bavarian Nordic Company Information Table 19. Bavarian Nordic Business Overview Table 20. Bavarian Nordic Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Bavarian Nordic Pediatric Vaccines Product Portfolio Table 22. Bavarian Nordic Recent Developments Table 23. Bharat Biotech Company Information Table 24. Bharat Biotech Business Overview Table 25. Bharat Biotech Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Bharat Biotech Pediatric Vaccines Product Portfolio Table 27. Bharat Biotech Recent Developments Table 28. Crucell Company Information Table 29. Crucell Business Overview Table 30. Crucell Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Crucell Pediatric Vaccines Product Portfolio Table 32. Crucell Recent Developments Table 33. Dynavax Company Information Table 34. Dynavax Business Overview Table 35. Dynavax Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Dynavax Pediatric Vaccines Product Portfolio Table 37. Dynavax Recent Developments Table 38. LG Life Sciences Company Information Table 39. LG Life Sciences Business Overview Table 40. LG Life Sciences Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. LG Life Sciences Pediatric Vaccines Product Portfolio Table 42. LG Life Sciences Recent Developments Table 43. Lupin Company Information Table 44. Lupin Business Overview Table 45. Lupin Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Lupin Pediatric Vaccines Product Portfolio Table 47. Lupin Recent Developments Table 48. Mitsubishi Tanabe Pharma Company Information Table 49. Mitsubishi Tanabe Pharma Business Overview Table 50. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio Table 52. Mitsubishi Tanabe Pharma Recent Developments Table 53. S K Chemicals Company Information Table 54. S K Chemicals Business Overview Table 55. S K Chemicals Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. S K Chemicals Pediatric Vaccines Product Portfolio Table 57. S K Chemicals Recent Developments Table 58. Serum Institute of India Company Information Table 59. Serum Institute of India Business Overview Table 60. Serum Institute of India Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Serum Institute of India Pediatric Vaccines Product Portfolio Table 62. Serum Institute of India Recent Developments Table 63. Sinovac Biotech Company Information Table 64. Sinovac Biotech Business Overview Table 65. Sinovac Biotech Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Sinovac Biotech Pediatric Vaccines Product Portfolio Table 67. Sinovac Biotech Recent Developments Table 68. AstraZeneca Company Information Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. AstraZeneca Pediatric Vaccines Product Portfolio Table 72. AstraZeneca Recent Developments Table 73. Baxter Company Information Table 74. Baxter Business Overview Table 75. Baxter Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Baxter Pediatric Vaccines Product Portfolio Table 77. Baxter Recent Developments Table 78. GlaxoSmithKline Company Information Table 79. GlaxoSmithKline Business Overview Table 80. GlaxoSmithKline Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. GlaxoSmithKline Pediatric Vaccines Product Portfolio Table 82. GlaxoSmithKline Recent Developments Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Pediatric Vaccines Product Portfolio Table 87. Pfizer Recent Developments Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Merck Pediatric Vaccines Product Portfolio Table 92. Merck Recent Developments Table 93. Novartis Company Information Table 94. Novartis Business Overview Table 95. Novartis Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Novartis Pediatric Vaccines Product Portfolio Table 97. Novartis Recent Developments Table 98. Sanofi Company Information Table 99. Sanofi Business Overview Table 100. Sanofi Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Sanofi Pediatric Vaccines Product Portfolio Table 102. Sanofi Recent Developments Table 103. Shenzhen Kangtai Biological Products Company Information Table 104. Shenzhen Kangtai Biological Products Business Overview Table 105. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio Table 107. Shenzhen Kangtai Biological Products Recent Developments Table 108. Takeda Pharmaceutical Company Information Table 109. Takeda Pharmaceutical Business Overview Table 110. Takeda Pharmaceutical Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Takeda Pharmaceutical Pediatric Vaccines Product Portfolio Table 112. Takeda Pharmaceutical Recent Developments Table 113. Janssen Company Information Table 114. Janssen Business Overview Table 115. Janssen Pediatric Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Janssen Pediatric Vaccines Product Portfolio Table 117. Janssen Recent Developments Table 118. Global Pediatric Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Pediatric Vaccines Sales by Region (2021-2026) & (W Units) Table 120. Global Pediatric Vaccines Sales Market Share by Region (2021-2026) Table 121. Global Pediatric Vaccines Sales by Region (2027-2032) & (W Units) Table 122. Global Pediatric Vaccines Sales Market Share by Region (2027-2032) Table 123. Global Pediatric Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Pediatric Vaccines Revenue Market Share by Region (2021-2026) Table 125. Global Pediatric Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Pediatric Vaccines Revenue Market Share by Region (2027-2032) Table 127. North America Pediatric Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 129. North America Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 130. North America Pediatric Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Pediatric Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Pediatric Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 134. Europe Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 135. Europe Pediatric Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Pediatric Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Pediatric Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 139. Asia Pacific Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 140. Asia Pacific Pediatric Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Pediatric Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Pediatric Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 144. South America Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 145. South America Pediatric Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Pediatric Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Pediatric Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Pediatric Vaccines Sales by Country (2021-2026) & (W Units) Table 149. Middle East and Africa Pediatric Vaccines Sales by Country (2027-2032) & (W Units) Table 150. Middle East and Africa Pediatric Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Pediatric Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Pediatric Vaccines Sales by Type (2021-2026) & (W Units) Table 153. Global Pediatric Vaccines Sales by Type (2027-2032) & (W Units) Table 154. Global Pediatric Vaccines Sales Market Share by Type (2021-2026) Table 155. Global Pediatric Vaccines Sales Market Share by Type (2027-2032) Table 156. Global Pediatric Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Pediatric Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Pediatric Vaccines Revenue Market Share by Type (2021-2026) Table 159. Global Pediatric Vaccines Revenue Market Share by Type (2027-2032) Table 160. Global Pediatric Vaccines Price by Type (2021-2026) & (US$/Unit) Table 161. Global Pediatric Vaccines Price by Type (2027-2032) & (US$/Unit) Table 162. Global Pediatric Vaccines Sales by Application (2021-2026) & (W Units) Table 163. Global Pediatric Vaccines Sales by Application (2027-2032) & (W Units) Table 164. Global Pediatric Vaccines Sales Market Share by Application (2021-2026) Table 165. Global Pediatric Vaccines Sales Market Share by Application (2027-2032) Table 166. Global Pediatric Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Pediatric Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Pediatric Vaccines Revenue Market Share by Application (2021-2026) Table 169. Global Pediatric Vaccines Revenue Market Share by Application (2027-2032) Table 170. Global Pediatric Vaccines Price by Application (2021-2026) & (US$/Unit) Table 171. Global Pediatric Vaccines Price by Application (2027-2032) & (US$/Unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Pediatric Vaccines Distributors List Table 175. Pediatric Vaccines Customers List Table 176. Pediatric Vaccines Industry Trends Table 177. Pediatric Vaccines Industry Drivers Table 178. Pediatric Vaccines Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Pediatric Vaccines Product Image Figure 5. Global Pediatric Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Pediatric Vaccines Market Size (2021-2032) & (US$ Million) Figure 7. Global Pediatric Vaccines Sales (2021-2032) & (W Units) Figure 8. Global Pediatric Vaccines Average Price (US$/Unit) & (2021-2032) Figure 9. Meningococcal Diseases Product Image Figure 10. Influenza Product Image Figure 11. Hepatitis Product Image Figure 12. Pneumococcal Diseases Product Image Figure 13. Diphtheria Product Image Figure 14. Others Product Image Figure 15. Infant Product Image Figure 16. Newborn Product Image Figure 17. Dolescent Product Image Figure 18. Child Product Image Figure 19. Global Pediatric Vaccines Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Pediatric Vaccines, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Pediatric Vaccines Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Pediatric Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Pediatric Vaccines Sales by Region in 2025 Figure 25. Global Pediatric Vaccines Revenue by Region in 2025 Figure 26. North America Pediatric Vaccines Market Size by Country in 2025 Figure 27. North America Pediatric Vaccines Sales Market Share by Country (2021-2032) Figure 28. North America Pediatric Vaccines Revenue Market Share by Country (2021-2032) Figure 29. United States Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Mexico Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Europe Pediatric Vaccines Market Size by Country in 2025 Figure 33. Europe Pediatric Vaccines Sales Market Share by Country (2021-2032) Figure 34. Europe Pediatric Vaccines Revenue Market Share by Country (2021-2032) Figure 35. Germany Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. France Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. U.K. Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Italy Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Russia Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Spain Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Netherlands Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Switzerland Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Sweden Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Poland Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Asia Pacific Pediatric Vaccines Market Size by Country in 2025 Figure 46. Asia Pacific Pediatric Vaccines Sales Market Share by Country (2021-2032) Figure 47. Asia Pacific Pediatric Vaccines Revenue Market Share by Country (2021-2032) Figure 48. China Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Japan Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South Korea Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. India Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Australia Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Taiwan Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Southeast Asia Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Southeast Asia Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. South America Pediatric Vaccines Market Size by Country in 2025 Figure 57. South America Pediatric Vaccines Sales Market Share by Country (2021-2032) Figure 58. South America Pediatric Vaccines Revenue Market Share by Country (2021-2032) Figure 59. Brazil Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Argentina Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Chile Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Middle East and Africa Pediatric Vaccines Market Size by Country in 2025 Figure 63. Middle East and Africa Pediatric Vaccines Sales Market Share by Country (2021-2032) Figure 64. Middle East and Africa Pediatric Vaccines Revenue Market Share by Country (2021-2032) Figure 65. Egypt Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. South Africa Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Israel Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Türkiye Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 69. GCC Countries Pediatric Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 70. Global Pediatric Vaccines Sales Market Share by Type (2021-2032) Figure 71. Global Pediatric Vaccines Revenue Market Share by Type (2021-2032) Figure 72. Global Pediatric Vaccines Price (US$/Unit) by Type (2021-2032) Figure 73. Global Pediatric Vaccines Sales Market Share by Application (2021-2032) Figure 74. Global Pediatric Vaccines Revenue Market Share by Application (2021-2032) Figure 75. Global Pediatric Vaccines Price (US$/Unit) by Application (2021-2032) Figure 76. Pediatric Vaccines Value Chain Figure 77. Pediatric Vaccines Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Pediatric Vaccines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Meningococcal Diseases
  • Influenza
  • Hepatitis
  • Pneumococcal Diseases
  • Diphtheria
  • Others
Applications
  • Infant
  • Newborn
  • Dolescent
  • Child
Companies covered
  • Bavarian Nordic
  • Bharat Biotech
  • Crucell
  • Dynavax
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • S K Chemicals
  • Serum Institute of India
  • Sinovac Biotech
  • AstraZeneca
  • Baxter
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis
  • Sanofi
  • Shenzhen Kangtai Biological Products
  • Takeda Pharmaceutical
  • Janssen

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Pediatric Vaccines Market Size (2021-2032)
  4. 2.2.2 Global Pediatric Vaccines Sales (2021-2032)
  5. 2.2.3 Global Pediatric Vaccines Market Average Price (2021-2032)
  6. 2.3 Pediatric Vaccines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Meningococcal Diseases
  9. 2.3.3 Influenza
  10. 2.3.4 Hepatitis
  11. 2.3.5 Pneumococcal Diseases
  12. 2.3.6 Diphtheria
  13. 2.3.7 Others
  14. 2.4 Pediatric Vaccines by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Infant
  17. 2.4.3 Newborn
  18. 2.4.4 Dolescent
  19. 2.4.5 Child
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Pediatric Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Pediatric Vaccines Sales (W Units) of Manufacturers (2021-2026)
  3. 3.3 Global Pediatric Vaccines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Pediatric Vaccines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Pediatric Vaccines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Pediatric Vaccines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Pediatric Vaccines, Product Type & Application
  8. 3.8 Global Manufacturers of Pediatric Vaccines, Established Date
  9. 3.9 Global Pediatric Vaccines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Bavarian Nordic
  2. 4.1.1 Bavarian Nordic Company Information
  3. 4.1.2 Bavarian Nordic Business Overview
  4. 4.1.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
  6. 4.1.5 Bavarian Nordic Recent Developments
  7. 4.2 Bharat Biotech
  8. 4.2.1 Bharat Biotech Company Information
  9. 4.2.2 Bharat Biotech Business Overview
  10. 4.2.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Bharat Biotech Pediatric Vaccines Product Portfolio
  12. 4.2.5 Bharat Biotech Recent Developments
  13. 4.3 Crucell
  14. 4.3.1 Crucell Company Information
  15. 4.3.2 Crucell Business Overview
  16. 4.3.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Crucell Pediatric Vaccines Product Portfolio
  18. 4.3.5 Crucell Recent Developments
  19. 4.4 Dynavax
  20. 4.4.1 Dynavax Company Information
  21. 4.4.2 Dynavax Business Overview
  22. 4.4.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Dynavax Pediatric Vaccines Product Portfolio
  24. 4.4.5 Dynavax Recent Developments
  25. 4.5 LG Life Sciences
  26. 4.5.1 LG Life Sciences Company Information
  27. 4.5.2 LG Life Sciences Business Overview
  28. 4.5.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 LG Life Sciences Pediatric Vaccines Product Portfolio
  30. 4.5.5 LG Life Sciences Recent Developments
  31. 4.6 Lupin
  32. 4.6.1 Lupin Company Information
  33. 4.6.2 Lupin Business Overview
  34. 4.6.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Lupin Pediatric Vaccines Product Portfolio
  36. 4.6.5 Lupin Recent Developments
  37. 4.7 Mitsubishi Tanabe Pharma
  38. 4.7.1 Mitsubishi Tanabe Pharma Company Information
  39. 4.7.2 Mitsubishi Tanabe Pharma Business Overview
  40. 4.7.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
  42. 4.7.5 Mitsubishi Tanabe Pharma Recent Developments
  43. 4.8 S K Chemicals
  44. 4.8.1 S K Chemicals Company Information
  45. 4.8.2 S K Chemicals Business Overview
  46. 4.8.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 S K Chemicals Pediatric Vaccines Product Portfolio
  48. 4.8.5 S K Chemicals Recent Developments
  49. 4.9 Serum Institute of India
  50. 4.9.1 Serum Institute of India Company Information
  51. 4.9.2 Serum Institute of India Business Overview
  52. 4.9.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Serum Institute of India Pediatric Vaccines Product Portfolio
  54. 4.9.5 Serum Institute of India Recent Developments
  55. 4.10 Sinovac Biotech
  56. 4.10.1 Sinovac Biotech Company Information
  57. 4.10.2 Sinovac Biotech Business Overview
  58. 4.10.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
  60. 4.10.5 Sinovac Biotech Recent Developments
  61. 4.11 AstraZeneca
  62. 4.11.1 AstraZeneca Company Information
  63. 4.11.2 AstraZeneca Business Overview
  64. 4.11.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 AstraZeneca Pediatric Vaccines Product Portfolio
  66. 4.11.5 AstraZeneca Recent Developments
  67. 4.12 Baxter
  68. 4.12.1 Baxter Company Information
  69. 4.12.2 Baxter Business Overview
  70. 4.12.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Baxter Pediatric Vaccines Product Portfolio
  72. 4.12.5 Baxter Recent Developments
  73. 4.13 GlaxoSmithKline
  74. 4.13.1 GlaxoSmithKline Company Information
  75. 4.13.2 GlaxoSmithKline Business Overview
  76. 4.13.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
  78. 4.13.5 GlaxoSmithKline Recent Developments
  79. 4.14 Pfizer
  80. 4.14.1 Pfizer Company Information
  81. 4.14.2 Pfizer Business Overview
  82. 4.14.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Pfizer Pediatric Vaccines Product Portfolio
  84. 4.14.5 Pfizer Recent Developments
  85. 4.15 Merck
  86. 4.15.1 Merck Company Information
  87. 4.15.2 Merck Business Overview
  88. 4.15.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Merck Pediatric Vaccines Product Portfolio
  90. 4.15.5 Merck Recent Developments
  91. 4.16 Novartis
  92. 4.16.1 Novartis Company Information
  93. 4.16.2 Novartis Business Overview
  94. 4.16.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Novartis Pediatric Vaccines Product Portfolio
  96. 4.16.5 Novartis Recent Developments
  97. 4.17 Sanofi
  98. 4.17.1 Sanofi Company Information
  99. 4.17.2 Sanofi Business Overview
  100. 4.17.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Sanofi Pediatric Vaccines Product Portfolio
  102. 4.17.5 Sanofi Recent Developments
  103. 4.18 Shenzhen Kangtai Biological Products
  104. 4.18.1 Shenzhen Kangtai Biological Products Company Information
  105. 4.18.2 Shenzhen Kangtai Biological Products Business Overview
  106. 4.18.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
  108. 4.18.5 Shenzhen Kangtai Biological Products Recent Developments
  109. 4.19 Takeda Pharmaceutical
  110. 4.19.1 Takeda Pharmaceutical Company Information
  111. 4.19.2 Takeda Pharmaceutical Business Overview
  112. 4.19.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
  114. 4.19.5 Takeda Pharmaceutical Recent Developments
  115. 4.20 Janssen
  116. 4.20.1 Janssen Company Information
  117. 4.20.2 Janssen Business Overview
  118. 4.20.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Janssen Pediatric Vaccines Product Portfolio
  120. 4.20.5 Janssen Recent Developments
5 Global Pediatric Vaccines Market Scenario by Region
  1. 5.1 Global Pediatric Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Pediatric Vaccines Sales by Region: 2021-2032
  3. 5.2.1 Global Pediatric Vaccines Sales by Region: 2021-2026
  4. 5.2.2 Global Pediatric Vaccines Sales by Region: 2027-2032
  5. 5.3 Global Pediatric Vaccines Revenue by Region: 2021-2032
  6. 5.3.1 Global Pediatric Vaccines Revenue by Region: 2021-2026
  7. 5.3.2 Global Pediatric Vaccines Revenue by Region: 2027-2032
  8. 5.4 North America Pediatric Vaccines Market Facts & Figures by Country
  9. 5.4.1 North America Pediatric Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Pediatric Vaccines Sales by Country (2021-2032)
  11. 5.4.3 North America Pediatric Vaccines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Pediatric Vaccines Market Facts & Figures by Country
  16. 5.5.1 Europe Pediatric Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Pediatric Vaccines Sales by Country (2021-2032)
  18. 5.5.3 Europe Pediatric Vaccines Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Pediatric Vaccines Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Pediatric Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Pediatric Vaccines Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Pediatric Vaccines Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Pediatric Vaccines Market Facts & Figures by Country
  41. 5.7.1 South America Pediatric Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Pediatric Vaccines Sales by Country (2021-2032)
  43. 5.7.3 South America Pediatric Vaccines Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Pediatric Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Pediatric Vaccines Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Pediatric Vaccines Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Pediatric Vaccines Sales by Type (2021-2032)
  2. 6.1.1 Global Pediatric Vaccines Sales by Type (2021-2032) & (W Units)
  3. 6.1.2 Global Pediatric Vaccines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Pediatric Vaccines Revenue by Type (2021-2032)
  5. 6.2.1 Global Pediatric Vaccines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Pediatric Vaccines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Pediatric Vaccines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Pediatric Vaccines Sales by Application (2021-2032)
  2. 7.1.1 Global Pediatric Vaccines Sales by Application (2021-2032) & (W Units)
  3. 7.1.2 Global Pediatric Vaccines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Pediatric Vaccines Revenue by Application (2021-2032)
  5. 7.2.1 Global Pediatric Vaccines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Pediatric Vaccines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Pediatric Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Pediatric Vaccines Value Chain Analysis
  2. 8.1.1 Pediatric Vaccines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Pediatric Vaccines Production Mode & Process
  5. 8.2 Pediatric Vaccines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Pediatric Vaccines Distributors
  8. 8.2.3 Pediatric Vaccines Customers
9 Global Pediatric Vaccines Analyzing Market Dynamics
  1. 9.1 Pediatric Vaccines Industry Trends
  2. 9.2 Pediatric Vaccines Industry Drivers
  3. 9.3 Pediatric Vaccines Industry Opportunities and Challenges
  4. 9.4 Pediatric Vaccines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst